These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 27166818)

  • 1. Interstitial Pressure in Pancreatic Ductal Adenocarcinoma Is Dominated by a Gel-Fluid Phase.
    DuFort CC; DelGiorno KE; Carlson MA; Osgood RJ; Zhao C; Huang Z; Thompson CB; Connor RJ; Thanos CD; Scott Brockenbrough J; Provenzano PP; Frost GI; Michael Shepard H; Hingorani SR
    Biophys J; 2016 May; 110(9):2106-19. PubMed ID: 27166818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mounting Pressure in the Microenvironment: Fluids, Solids, and Cells in Pancreatic Ductal Adenocarcinoma.
    DuFort CC; DelGiorno KE; Hingorani SR
    Gastroenterology; 2016 Jun; 150(7):1545-1557.e2. PubMed ID: 27072672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting the Tumor Stroma: the Biology and Clinical Development of Pegylated Recombinant Human Hyaluronidase (PEGPH20).
    Wong KM; Horton KJ; Coveler AL; Hingorani SR; Harris WP
    Curr Oncol Rep; 2017 Jul; 19(7):47. PubMed ID: 28589527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-Invasive Monitoring of Stromal Biophysics with Targeted Depletion of Hyaluronan in Pancreatic Ductal Adenocarcinoma.
    Maloney E; DuFort CC; Provenzano PP; Farr N; Carlson MA; Vohra R; Park J; Hingorani SR; Lee D
    Cancers (Basel); 2019 Jun; 11(6):. PubMed ID: 31167451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oncotic pressure in solid tumors is elevated.
    Stohrer M; Boucher Y; Stangassinger M; Jain RK
    Cancer Res; 2000 Aug; 60(15):4251-5. PubMed ID: 10945638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PEGPH20, a PEGylated human hyaluronidase, induces radiosensitization by reoxygenation in pancreatic cancer xenografts. A molecular imaging study.
    Seki T; Saida Y; Kishimoto S; Lee J; Otowa Y; Yamamoto K; Chandramouli GV; Devasahayam N; Mitchell JB; Krishna MC; Brender JR
    Neoplasia; 2022 Aug; 30():100793. PubMed ID: 35523073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyaluronan, fluid pressure, and stromal resistance in pancreas cancer.
    Provenzano PP; Hingorani SR
    Br J Cancer; 2013 Jan; 108(1):1-8. PubMed ID: 23299539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Separation of Solid Stress From Interstitial Fluid Pressure in Pancreas Cancer Correlates With Collagen Area Fraction.
    Nieskoski MD; Marra K; Gunn JR; Kanick SC; Doyley MM; Hasan T; Pereira SP; Stuart Trembly B; Pogue BW
    J Biomech Eng; 2017 Jun; 139(6):0610021-8. PubMed ID: 28388715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microvascular pressure is the principal driving force for interstitial hypertension in solid tumors: implications for vascular collapse.
    Boucher Y; Jain RK
    Cancer Res; 1992 Sep; 52(18):5110-4. PubMed ID: 1516068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyaluronan stimulates pancreatic cancer cell motility.
    Cheng XB; Kohi S; Koga A; Hirata K; Sato N
    Oncotarget; 2016 Jan; 7(4):4829-40. PubMed ID: 26684359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overcoming the stromal barrier for targeted delivery of HPMA copolymers to pancreatic tumors.
    Buckway B; Wang Y; Ray A; Ghandehari H
    Int J Pharm; 2013 Nov; 456(1):202-11. PubMed ID: 23933441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Salmonella-Based Therapy Targeting Indoleamine 2,3-Dioxygenase Coupled with Enzymatic Depletion of Tumor Hyaluronan Induces Complete Regression of Aggressive Pancreatic Tumors.
    Manuel ER; Chen J; D'Apuzzo M; Lampa MG; Kaltcheva TI; Thompson CB; Ludwig T; Chung V; Diamond DJ
    Cancer Immunol Res; 2015 Sep; 3(9):1096-107. PubMed ID: 26134178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Collagen Complexity Spatially Defines Microregions of Total Tissue Pressure in Pancreatic Cancer.
    Nieskoski MD; Marra K; Gunn JR; Hoopes PJ; Doyley MM; Hasan T; Trembly BS; Pogue BW
    Sci Rep; 2017 Aug; 7(1):10093. PubMed ID: 28855644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interstitial fluid pressure as a prognostic factor in cervical cancer following radiation therapy.
    Yeo SG; Kim JS; Cho MJ; Kim KH; Kim JS
    Clin Cancer Res; 2009 Oct; 15(19):6201-7. PubMed ID: 19773374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ECM-targeting bacteria enhance chemotherapeutic drug efficacy by lowering IFP in tumor mouse models.
    Kim JS; Park JE; Choi SH; Kang SW; Lee JH; Lee JS; Shin M; Park SH
    J Control Release; 2023 Mar; 355():199-210. PubMed ID: 36750146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of the vascular disrupting agent ZD6126 on interstitial fluid pressure and cell survival in tumors.
    Skliarenko JV; Lunt SJ; Gordon ML; Vitkin A; Milosevic M; Hill RP
    Cancer Res; 2006 Feb; 66(4):2074-80. PubMed ID: 16489007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting tumor architecture to favor drug penetration: a new weapon to combat chemoresistance in pancreatic cancer?
    Yu M; Tannock IF
    Cancer Cell; 2012 Mar; 21(3):327-9. PubMed ID: 22439929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of angiotensin II induced hypertension on tumor blood flow and interstitial fluid pressure.
    Zlotecki RA; Boucher Y; Lee I; Baxter LT; Jain RK
    Cancer Res; 1993 Jun; 53(11):2466-8. PubMed ID: 8495405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breaching the Castle Walls: Hyaluronan Depletion as a Therapeutic Approach to Cancer Therapy.
    Shepard HM
    Front Oncol; 2015; 5():192. PubMed ID: 26380222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Development of a Novel Therapeutic Strategy to Target Hyaluronan in the Extracellular Matrix of Pancreatic Ductal Adenocarcinoma.
    Kudo D; Suto A; Hakamada K
    Int J Mol Sci; 2017 Mar; 18(3):. PubMed ID: 28282922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.